Related references
Note: Only part of the references are listed.Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia
Galo Peralta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?
Andrew F. Shorr et al.
CRITICAL CARE MEDICINE (2007)
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia
Andrew F. Shorr et al.
CRITICAL CARE MEDICINE (2007)
Ventilator-associated pneumonia:: Breaking the vicious circle of antibiotic overuse
Marc Leone et al.
CRITICAL CARE MEDICINE (2007)
Multidrug-resistant Acinetobacter baumannii bacteraemia:: clinical features, antimicrobial therapy and outcome
L. -C. Kuo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
Timothy H. Dellit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing enterobacteriaceae: Importance of inadequate initial antimicrobial treatment
Mario Tumbarello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era:: A new clinical challenge
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2006)
Targeted antibiotic management of ventilator-associated pneumonia
J. -Y. Fagon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Before-after study of a standardized hospital order set for the management of septic shock
Scott T. Micek et al.
CRITICAL CARE MEDICINE (2006)
Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay
Abigail Fraser et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Echinocandins in the management of invasive fungal infections, part 2
Michele I. Morris et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Methicillin-resistant Staphylococcus aureus sterile-site infection:: The importance of appropriate initial antimicrobial treatment
Garreft E. Schramm et al.
CRITICAL CARE MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia
Morin H. Kollef et al.
CHEST (2006)
Extended-spectrum β-lactamases and clinical outcomes:: Current data
R Ramphal et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs
D Berild et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment:: a prospective and randomized clinical trial of 381 patients
E Ruotsalainen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Diagnosis and management of Staphylococcus aureus bacteraemia
DH Mitchell et al.
INTERNAL MEDICINE JOURNAL (2005)
Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections:: The role of inadequate empirical antimicrobial therapy
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2005)
Impact of clinical guidelines in the management of severe hospital-acquired pneumonia
GWS Hoo et al.
CHEST (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Strategies to prevent antimicrobial resistance in the intensive care unit
MH Kollef et al.
CRITICAL CARE MEDICINE (2005)
Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae -: Variability by site of infection
EP Hyle et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment
ST Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Risk factors for mortality resulting from bloodstream infections in a pediatric intensive care unit
SH Armenian et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Current guidelines for the treatment of severe pneumonia and sepsis
KF Bodmann
CHEMOTHERAPY (2005)
Predictors of hospital mortality for patients with severe sepsis treated with drotrecogin alfa (activated)
ST Micek et al.
PHARMACOTHERAPY (2005)
Meropenem monotherapy for the treatment of hospital-acquired pneumonia: Results of a multicenter trial
SJ Berman et al.
JOURNAL OF CHEMOTHERAPY (2004)
Antibiotic therapy for Klebsiella pneumoniae bacteremia:: Implications of production of extended-spectrum β-lactamases
DL Paterson et al.
CLINICAL INFECTIOUS DISEASES (2004)
Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Treatment and outcome of Pseudomonas aeruginosa bacteraemia:: an antibiotic pharmacodynamic analysis
SA Zelenitsky et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Community-acquired bloodstream infection in critically ill adult patients:: Impact of shock and inappropriate antibiotic therapy on survival
J Vallés et al.
CHEST (2003)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
RG Wunderink et al.
CLINICAL THERAPEUTICS (2003)
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: A multicenter, prospective, randomized, open-label study
M West et al.
CLINICAL THERAPEUTICS (2003)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
S Harbarth et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Appropriate empirical antibacterial therapy for nosocmial infections - Getting it right the first time
MH Kollef
DRUGS (2003)
A comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: A multicenter, prospective, randomized, investigator-blinded, parallel-group study
CM Fogarty et al.
CLINICAL THERAPEUTICS (2002)
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia
M Iregui et al.
CHEST (2002)
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia
EH Ibrahim et al.
CRITICAL CARE MEDICINE (2001)
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients:: a prospective randomized multicenter trial
F Alvarez-Lerma et al.
INTENSIVE CARE MEDICINE (2001)
Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia
FA Lerma
JOURNAL OF CHEMOTHERAPY (2001)
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
TK Jellison et al.
PHARMACOTHERAPY (2001)
Treatment of severe nosocomial pneumonia:: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin
A Torres et al.
THORAX (2000)
Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices
NH Kollef et al.
CRITICAL CARE MEDICINE (2000)
Clinical impact of an infectious disease service on the management of bloodstream infection
U Fluckiger et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit
C Verwaest
CLINICAL MICROBIOLOGY AND INFECTION (2000)
Share Paper
